| 臺大學術典藏 |
2022-03-22T08:25:21Z |
Design of one-dimensional acoustic metamaterials using machine learning and cell concatenation
|
Wu R.-T;Liu T.-W;Jahanshahi M.R;Semperlotti F.; Wu R.-T; Liu T.-W; Jahanshahi M.R; Semperlotti F.; RIH-TENG WU |
| 臺大學術典藏 |
2022-03-09T03:12:24Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; HUEI-WEN CHEN; Yu S.-L.; Liu T.-W.; Chang G.-C. |
| 臺大學術典藏 |
2022-02-14T05:27:14Z |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; HSIU-PO WANG; Wang T.-E.; Bai L.-Y.; Wu M.-S.; Chen L.-T.; Liu T.-W.; Yang Y.-H. |
| 臺大學術典藏 |
2022-01-25T07:24:16Z |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; Wang H.-P.; Wang T.-E.; Bai L.-Y.; MING-SHIANG WU; Chen L.-T.; Liu T.-W.; Yang Y.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:20Z |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
|
Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Chen P.-J.; CHUN-JEN LIU; Yu M.-L. |
| 國立成功大學 |
2022 |
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
|
Chien, L.-H.;Chen, T.-Y.;Chen, Chen C.-H.;Chen, K.-Y.;Hsiao, C.-F.;Chang, G.-C.;Tsai, Y.-H.;Su, W.-C.;Huang, M.-S.;Chen, Y.-M.;Chen, Chen C.-Y.;Liang, S.-K.;Chen, Chen C.-Y.;Wang, C.-L.;Hung, Hung H.-H.;Jiang, H.-F.;Hu, J.-W.;Rothman, N.;Lan, Q.;Liu, T.-W.;Chen, Chen C.-J.;Yang, P.-C.;Chang, I.-S.;Hsiung, C.A. |
| 國立成功大學 |
2022 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T. |
| 國立成功大學 |
2022 |
Clinical Outcomes of Taiwanese Patients with Resected Oral Cavity Squamous Cell Carcinoma Who Underwent Reconstruction with Free Versus Local Flaps
|
Liao, C.-T.;Wen, Y.-W.;Lee, S.-R.;Ng, S.-H.;Liu, T.-W.;Tsai, S.-T.;Tsai, M.-H.;Lin, J.-C.;Chien, Chien C.-Y.;Lou, P.-J.;Wang, C.-P.;Chu, P.-Y.;Leu, Y.-S.;Tsai, K.-Y.;Terng, S.-D.;Chen, T.-M.;Wang, C.-H.;Chen, W.-C.;Lee, Lee L.-Y.;Lin, C.-Y.;Wang, H.-M.;Fang, T.-J.;Huang, S.-F.;Kang, C.-J.;Chang, K.-P.;Yen, T.-C.;Yang, L.-Y.;Lin, C.-H.;Group, for the Taiwan Oral Cavity Cancer Advisory |
| 臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-18T04:57:45Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C; Leu Y.-S; Chiang C.-J; JENG-YUH KO; Wang C.-P; Yang T.-L; Chen T.-C; Chen C.-N; Chen H.-L; Liao C.-T; Tsai S.-T; Lin J.-C; Chu P.-Y; Tsai K.-Y; Tsai M.-H; Huang H.-C; Yang M.-H; Wu Y.-H; Terng S.-D; Chien C.-Y; Liu T.-W; Lee W.-C; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-15T07:48:06Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C; Leu Y.-S; Chiang C.-J; JENG-YUH KO; Wang C.-P; Yang T.-L; Chen T.-C; Chen C.-N; Chen H.-L; Liao C.-T; Tsai S.-T; Lin J.-C; Chu P.-Y; Tsai K.-Y; Tsai M.-H; Huang H.-C; Yang M.-H; Wu Y.-H; Terng S.-D; Chien C.-Y; Liu T.-W; Lee W.-C; Lou P.-J. |
| 臺大學術典藏 |
2021-11-10T00:53:38Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; Chen H.-L.; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; HUAI-CHENG HUANG; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. |
| 臺大學術典藏 |
2021-11-03T02:35:04Z |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; HSIN-LIN CHEN; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; Huang H.-C.; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. |
| 臺大學術典藏 |
2021-09-04T05:17:07Z |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
|
Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Chen P.-J.; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:52Z |
Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report
|
Chen Y.C.; Wang C.H.; Lin D.T.; Lui P.T.; ANN-LII CHENG; Liu T.W.; Tsay W.; Tien H.F.; Liu M.C.; Chuu W.M. |
| 臺大學術典藏 |
2021-09-01T02:02:51Z |
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately?
|
ANN-LII CHENG; Chen Y.-C.; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; Tien H.-F.; Tsai W.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:51Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
ANN-LII CHENG; Chen Y.-C.; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; Lai H.-S.; Liu T.-W.; Tien H.-F.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer
|
Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:30Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; ANN-LII CHENG; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:27Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:16Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:35:20Z |
Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma
|
Shiah H.-S.; Chao Y.; Chen L.-T.; Yao T.-J.; Huang J.-D.; Chang J.-Y.; PEI-JER CHEN; Chuang T.-R.; Chin Y.-H.; Whang-Peng J.; Liu T.-W. |
| 臺大學術典藏 |
2021-07-03T03:35:05Z |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu C.; Hsiung C.A.; Su I.-J.; Hwang W.-S.; Wang M.-C.; Lin S.-F.; Lin T.-H.; Hsiao H.-H.; Young J.-H.; Chang M.-C.; Liao Y.-M.; Li C.-C.; Wu H.-B.; Tien H.-F.; Chao T.-Y.; Liu T.-W.; Cheng A.-L.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:10Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Hsu C.; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; Tien H.-F.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:38Z |
Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan
|
Hsieh M.-H.; Yeh M.-L.; Su T.-H.; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Liu C.-J.; Yu M.-L. |
| 臺大學術典藏 |
2021-07-03T03:33:36Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:33:29Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-06-21T07:27:54Z |
Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer
|
Lin S.-M.; Ku H.-Y.; CHE-YU HSU; Wang C.-L.; Chang G.-C.; Chang C.-S.; Liu T.-W. |
| 臺大學術典藏 |
2021-05-26T09:08:43Z |
Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report
|
YAO-CHANG CHEN; Wang C.H.; Lin D.T.; Lui P.T.; Cheng A.L.; Liu T.W.; Tsay W.; Tien H.F.; Liu M.C.; Chuu W.M. |
| 臺大學術典藏 |
2021-05-26T09:08:41Z |
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately?
|
Cheng A.-L.; YAO-CHANG CHEN; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; Tien H.-F.; Tsai W.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-05-26T09:08:40Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
Cheng A.-L.; YAO-CHANG CHEN; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; Lai H.-S.; Liu T.-W.; Tien H.-F.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-05-26T09:08:39Z |
Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens
|
Lin M.-T.; YAO-CHANG CHEN; Liu T.-W.; Tien H.-F.; Liu M.-C.; Wang C.-H.; Shen M.-C.; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:20Z |
Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades - Should peripheral T-cell lymphoma be considered separately?
|
Cheng A.-L.; Chen Y.-C.; Wang C.-H.; Su I.-J.; Hsieh H.-C.; Chang J.-Y.; Hwang W.-S.; Su W.-C.; Liu T.-W.; Tien H.-F.; Tsai W.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:19Z |
Adult non-Hodgkin's lymphoma in Taiwan area: A clinicopathologic study of 123 cases based on working formulation classification
|
Cheng A.-L.; Chen Y.-C.; Su I.-J.; Wang C.-H.; Hsieh H.-C.; Chen C.-L.; Lai H.-S.; Liu T.-W.; Tien H.-F.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-25T06:36:19Z |
Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens
|
Lin M.-T.; Chen Y.-C.; Liu T.-W.; Tien H.-F.; Liu M.-C.; Wang C.-H.; MING-CHING SHEN; Liu C.-H. |
| 臺大學術典藏 |
2021-05-07T06:02:30Z |
Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status
|
Hsu C.-H.; Tseng C.-H.; CHUN-JU CHIANG; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.-H.; Chiu C.-H.; Huang M.-S.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Tsai C.-M.; Chou T.-Y.; Lin K.-C.; Tsai M.-H.; Lee W.-C.; Ku H.-Y.; Liu T.-W.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2021-05-07T06:02:29Z |
EGFR mutation, smoking, and gender in advanced lung adenocarcinoma
|
Tseng C.-H.;Chun-Ju Chiang;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Wang C.-L.;Chen C.-Y.;Yen S.H.;Tsai C.-M.;Huang M.-S.;Ho C.-C.;Yu C.-J.;Tsai Y.-H.;Chen J.-S.;Chou T.-Y.;Tsai M.-H.;Chen H.-Y.;Su K.-Y.;Chen J.J.W.;Chen H.-W.;Yu S.-L.;Liu T.-W.;Chang G.-C.; Tseng C.-H.; CHUN-JU CHIANG; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; Su K.-Y.; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Liu T.-W.; Chang G.-C. |
| 臺大學術典藏 |
2021-05-07T06:02:21Z |
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome—A Taiwan Cancer Registry national database analysis
|
Cheng Y.-J.;Tsai M.-H.;Chun-Ju Chiang;Tsai S.-T.;Liu T.-W.;Lou P.-J.;Liao C.-T.;Lin J.-C.;Chang J.T.-C.;Tsai M.-H.;Chu P.-Y.;Leu Y.-S.;Tsai K.-Y.;Terng S.-D.;Chien C.-Y.;Yang M.-H.;Hao S.-P.;Wang C.-C.;Tsai M.-H.;Chen H.H.W.;Kuo C.;Wu Y.-H.; Cheng Y.-J.; Tsai M.-H.; CHUN-JU CHIANG; Tsai S.-T.; Liu T.-W.; Lou P.-J.; Liao C.-T.; Lin J.-C.; Chang J.T.-C.; Tsai M.-H.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chien C.-Y.; Yang M.-H.; Hao S.-P.; Wang C.-C.; Tsai M.-H.; Chen H.H.W.; Kuo C.; Wu Y.-H. |
| 臺大學術典藏 |
2021-05-07T06:02:18Z |
The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan
|
Tseng C.-H.;Tsuang B.-J.;Chun-Ju Chiang;Ku K.-C.;Tseng J.-S.;Yang T.-Y.;Hsu K.-H.;Chen K.-C.;Yu S.-L.;Lee W.-C.;Liu T.-W.;Chan C.-C.;Chang G.-C.; Tseng C.-H.; Tsuang B.-J.; CHUN-JU CHIANG; Ku K.-C.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Yu S.-L.; Lee W.-C.; Liu T.-W.; Chan C.-C.; Chang G.-C. |
| 臺大學術典藏 |
2021-04-28T06:58:18Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L.; Hsiao C.F.; Ting L.L.; Ko J.Y.; CHUN-WEI WANG; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
| 臺大學術典藏 |
2021-03-18T02:02:18Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.;Tai J.J.;Chen L.-T.;Wu M.-S.;Yeh K.-H.;Lin C.-W.;Wang T.-E.;Wang H.-P.;Yu F.-J.;Liou J.-M.;Hsiao C.-F.;Cheng T.-Y.;Yeh H.-J.;Ko C.-W.;Chen M.-J.;Lo G.-H.;Hsu P.-I.;Chang C.-S.;Hwang W.-S.;Chuang S.-S.;Lee H.-W.;Chia-Tung Shun;Chiu C.-F.;Wang W.-M.;Hsieh C.-Y.;Liu T.-W.;Lin J.-T.;Kuo S.-H.;Cheng A.-L.; Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; Cheng T.-Y.; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; CHIA-TUNG SHUN; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-10T07:09:07Z |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai H.-J.; Tai J.J.; Chen L.-T.; Wu M.-S.; Yeh K.-H.; Lin C.-W.; Wang T.-E.; Wang H.-P.; Yu F.-J.; Liou J.-M.; Hsiao C.-F.; TSU-YAO CHENG; Yeh H.-J.; Ko C.-W.; Chen M.-J.; Lo G.-H.; Hsu P.-I.; Chang C.-S.; Hwang W.-S.; Chuang S.-S.; Lee H.-W.; Shun C.-T.; Chiu C.-F.; Wang W.-M.; Hsieh C.-Y.; Liu T.-W.; Lin J.-T.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
|
Wang C.-C.;Chang J.-Y.;Liu T.-W.;Lin C.-Y.;Yu Y.-C.;Ruey-Long Hong; Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Ruey-Long Hong;Hsiao C.F.;Ting L.L.;Ko J.Y.;Wang C.W.;Chang J.T.C.;Lou P.J.;Wang H.M.;Tsai M.H.;Lai S.C.;Liu T.W.; RUEY-LONG HONG; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Terminally Ill Taiwanese Cancer Patients�� and Family Caregivers�� Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies
|
Liu T.-W.;Wen F.-H.;Wang C.-H.;Ruey-Long Hong;Chow J.-M.;Chen J.-S.;Chiu C.-F.;Tang S.T.; Liu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T. |
